Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL vs EFGARTIGIMOD ALFA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL vs EFGARTIGIMOD ALFA: Safety Overview

Metric EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL EFGARTIGIMOD ALFA
Total FAERS Reports 18,558 249
Deaths Reported 429 26
Death Rate 2.3% 10.4%
Hospitalizations 1,627 115
Average Patient Age 48.7 yrs 54.0 yrs
% Female Patients 25.7% 82.5%
Manufacturer N/A argenx US
Route N/A INTRAVENOUS
Marketing Status N/A Prescription